SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-454542
Filing Date
2014-12-29
Accepted
2014-12-29 08:34:37
Documents
7
Period of Report
2014-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d843114d8k.htm 8-K 17086
2 EX-10.1 d843114dex101.htm EX-10.1 24690
3 EX-10.2 d843114dex102.htm EX-10.2 34141
4 EX-99.1 d843114dex991.htm EX-99.1 15315
5 GRAPHIC g8431141.jpg GRAPHIC 8344
6 GRAPHIC g8431142.jpg GRAPHIC 8036
7 GRAPHIC g8431143.jpg GRAPHIC 7135
  Complete submission text file 0001193125-14-454542.txt   125350
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 141310772
SIC: 8731 Services-Commercial Physical & Biological Research